Increasingly more products are being reclassified or switched from POM to P, providing a larger repertoire of medicines which pharmacists can select from to treat their patients.

We monitor POM to P switches, and actively assess and work towards producing guidance where we consider this is needed by members.

Click on the links below to view guidance produced:

• Amorolfine nail lacquer (May 2006)
• Azithromycin (November 2008)
• Chloramphenicol eye drops (November 2011)
• Omeprazole (May 2011)
• Orlistat (July 2011)
• Sumatriptan (June 2006)
• Tamsulosin (March 2010)
• Tranexamic acid P medicine (January 2011)